Publication | Closed Access

Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement

Hematological MalignancyOncologyAml1/eto RearrangementMedicineMixed-phenotype Acute LeukemiaHematologyMyeloid NeoplasiaPathologyAdult T-cell Leukemia-lymphomaMolecular DiagnosticsRadiation OncologyCancer ResearchMinimal Residual DiseaseRadiologyHealth Sciences